Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRDN | CCLE | pan-cancer | AAC | 0.32 | 4e-11 |
mRNA | LDB1 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
mRNA | EGFL7 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
mRNA | OSCAR | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
mRNA | RFESD | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-11 |
mRNA | KCNH2 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
mRNA | OR51B5 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | SVOPL | CCLE | pan-cancer | AAC | 0.33 | 5e-11 |
mRNA | PRKCQ | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-11 |
mRNA | C5AR2 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |